NCT02481583 is a Phase 1 clinical trial of Levosulpiride in Dyspepsia, sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

What drugs are being tested in NCT02481583?

Interventions in NCT02481583: Levosulpiride.

Is NCT02481583 still recruiting?

NCT02481583 is currently completed. Last updated 24 June 2015.

Last reviewed 2015-06-24 · How we verify

NCT02481583

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular and Intravenous Administration of Levosulpiride After Single and Multiple Doses in Fasting Healthy Chinese Volunteers

Completed Phase 1 Last updated 24 June 2015

What this trial tests

Phase 1 trial testing Levosulpiride in Dyspepsia in 42 participants. Completed in 1 May 2013.

Timeline

1 March 2013

Primary endpoint
1 May 2013

1 May 2013

Quick facts

Lead sponsor	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	42
Start date	1 March 2013
Primary completion	1 May 2013
Estimated completion	1 May 2013

Drugs / interventions tested

Levosulpiride (LEVOSULPIRIDE) — full drug profile →

Conditions studied

Dyspepsia — all drugs for Dyspepsia →

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Who can join

Adults 19 to 45, any sex, with Dyspepsia. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Cmax
Time frame: two days
Peak concentration
Area under the curve-AUC
Time frame: two days
Area under the curve - plasma concentration
Clearance-CL
Time frame: two days
Clearance
Apparent volume of distribution-V
Time frame: two days
The apparent volume of distribution

Sponsor's own description

The aim of this study was to characterise the pharmacokinetic properties and assess the safety of different formulations of levosulpiride in healthy Chinese volunteers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Tolerability and Pharmacokinetic Comparison of Oral, Intramuscular, and Intravenous Administration of Levosulpiride After Single and Multiple Dosing in Healthy Chinese Volunteers.
Xu M, Zhou Y, Ni Y, He X, et al · · 2015 · cited 10× · PMID 26404395 · DOI 10.1016/j.clinthera.2015.08.024

Verify or expand the search:

Other trials of Levosulpiride

Trials testing the same drug.

NCT04697641 — Helicobacter Pylori Eradication in Functional Dyspepsia · NA · completed

Other recruiting trials for Dyspepsia

Currently open trials in the same condition.

NCT06941545 — High Resolution Gastric Mapping and Gastroduodenal Manometry · NA · recruiting
NCT07261228 — The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper · recruiting
NCT06755671 — A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms · recruiting
NCT06422052 — Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspep · recruiting
NCT05810168 — Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia · NA · recruiting

Other Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials

Trials by the same sponsor.

NCT07521124 — ABC Maintenance Therapy for AML · NA · not yet recruiting
NCT07497243 — X-ray Assisted Diagnostic System · not yet recruiting
NCT07520123 — Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatiti · NA · not yet recruiting
NCT06970262 — FMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients · NA · recruiting
NCT07509424 — Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Lo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02481583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Last refreshed: 24 June 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02481583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing